Finance

Beta
Senarai
Sektor ekuiti
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Buka
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-1.50%
1,075.18
-16.33
-1.50%
—1,091.511,090.401,090.401,074.65——
SIXC
Communications
SIXC
Communications
SIXC
-0.33%
608.09
-2.02
-0.33%
—610.11610.11610.29606.17——
SIXE
Energy
SIXE
Energy
SIXE
+0.89%
1,248.96
+10.98
+0.89%
—1,237.981,237.831,252.411,225.03——
SIXI
Industrials
SIXI
Industrials
SIXI
-1.10%
1,725.54
-19.17
-1.10%
—1,744.711,740.951,747.291,721.57——
SIXM
Financials
SIXM
Financials
SIXM
-0.70%
635.67
-4.51
-0.70%
—640.18639.92643.19634.73——
SIXR
Staples
SIXR
Staples
SIXR
-1.08%
840.38
-9.20
-1.08%
—849.58845.27851.68840.00——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.79%
215.77
-1.71
-0.79%
—217.48217.48218.16215.51——
SIXT
Technology
SIXT
Technology
SIXT
+0.10%
3,264.07
+3.38
+0.10%
—3,260.693,273.363,287.813,240.78——
SIXU
Utilities
SIXU
Utilities
SIXU
-0.64%
936.42
-6.03
-0.64%
—942.45939.39948.80933.98——
SIXV
Health care
SIXV
Health care
SIXV
-0.24%
1,463.23
-3.57
-0.24%
—1,466.801,464.701,467.191,458.36——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.81%
2,377.98
-19.52
-0.81%
—2,397.502,395.032,412.012,370.64——
SILO:IDX
Siloam International Hospitals Tbk PT
IDR 2,480.00
-0.80%
(-20.00) 1H
4 Mei, 4:00:05 PTG GMT+7  ·   IDR
Semua simbol
SimbolPriceChange% Change
Generating top insights for SILO...
Buka
IDR 2,510
High
IDR 2,550
Low
IDR 2,480
Mkt. cap
32.26T
Avg. vol.
572.29K
Volume
278.30K
P/E ratio
28.95
52-wk high
IDR 2,880
52-wk low
IDR 1,830
EPS
IDR 86
Shares outstanding
13.01B
No. of employees
15K
News stories
From sources across the web
Profil
PT Siloam International Hospitals Tbk or Siloam Hospitals is a chain of healthcare facilities in Indonesia founded in 1996 by PT. Lippo Karawaci Tbk. It is a publicly listed company which is part of Lippo Group. Wikipedia
About Siloam International Hospitals Tbk PT
CEO-
Employees14.8K
Founded27 Ogo 1996
HeadquartersKota Tangerang, Banten, Indonesia
Sector-
Websitesiloamhospitals.com
Last report
13 Mei 2026
Fiscal Period
Q1 2026
Normalized EPS / Estimate
-/ -IDR
Revenue / Estimate
3.28T/ (- est.)IDR
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in IDR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in IDR
Jun 2025
Sep 2025
Dis 2025
Mac 2026
Revenue
3.07T
3.32T
3.42T
3.28T
Cost of goods sold
1.95T
2.08T
2.10T
2.03T
Cost of revenue
1.95T
2.08T
2.10T
2.03T
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
692.65B
722.64B
738.98B
790.71B
Operating expense
772.97B
769.58B
801.39B
837.71B
Total operating expenses
2.72T
2.85T
2.91T
2.86T
Operating income
346.00B
470.34B
516.10B
412.82B
Other non operating income
-7.32B
-6.84B
-9.94B
-
EBT including unusual items
308.64B
428.16B
475.15B
382.93B
EBT excluding unusual items
308.64B
428.16B
475.15B
382.93B
Income tax expense
88.02B
107.46B
108.10B
89.35B
Effective tax rate
28.52%
25.10%
22.75%
23.33%
Other operating expenses
80.32B
46.94B
62.41B
47.00B
Net income
210.84B
304.52B
351.32B
279.97B
Net profit margin
6.87%
9.17%
10.27%
8.54%
Earnings per share
-
-
-
-
Interest and investment income
4.91B
3.94B
5.88B
6.44B
Interest expense
-26.30B
-30.42B
-27.88B
-36.33B
Net interest expenses
-21.39B
-26.49B
-22.00B
-29.89B
Depreciation and amortization charges
-
-
-
-
EBITDA
469.14B
595.74B
643.43B
536.35B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

Tugasan saya
Anda belum membuat tugasan lagi
Tugasan anda akan dipaparkan di sini. Jadualkan tugasan dan manfaatkan Google Finance semasa anda tiada.
Templat
Ringkasan senarai amatan
Analisis prapasaran harian bagi senarai amatan anda
Pendapatan Akan Datang
Laporan pendapatan akan datang dalam minggu ini
Kemudahubahan & Jumlah yang Tidak Normal
Amaran awal kemudahubahan dan jumlah hari ini
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer